ROCKWELL MEDICAL, INC. Interest Income (Expense), Net
ROCKWELL MEDICAL, INC. (RMTI) reported Interest Income (Expense), Net of $367.08 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2020-03-17
- ROCKWELL MEDICAL, INC. interest income (expense), net for the quarter ending 2019-12-31 was $94.34K, a 91.21% increase year-over-year.
- ROCKWELL MEDICAL, INC. interest income (expense), net for the quarter ending 2019-09-30 was $80.73K, a 35.88% decline year-over-year.
- ROCKWELL MEDICAL, INC. interest income (expense), net for the quarter ending 2019-06-30 was $74.48K, a 60.43% decline year-over-year.
- ROCKWELL MEDICAL, INC. interest income (expense), net for the quarter ending 2019-03-31 was $117.53K, a 32.96% decline year-over-year.
- ROCKWELL MEDICAL, INC. interest income (expense), net for fiscal 2019 was $367.08K, a 31.47% decline from fiscal 2018.
- ROCKWELL MEDICAL, INC. interest income (expense), net for fiscal 2018 was $535.64K, a 32.22% decline from fiscal 2017.
- ROCKWELL MEDICAL, INC. interest income (expense), net for fiscal 2017 was $790.23K.
- ROCKWELL MEDICAL, INC. interest income (expense), net for fiscal 2014 was -$4.15M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $94.34K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $175.08K derived: sum of 2 quarters · filed 2020-03-17 | $249.55K derived: sum of 3 quarters · filed 2020-03-17 | $367.08K 10-K · filed 2020-03-17 | |
| 2019-09-30 | $80.73K 10-Q · filed 2019-11-12 | $155.21K derived: sum of 2 quarters · filed 2019-11-12 | $272.74K 10-Q · filed 2019-11-12 | $322.08K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2019-06-30 | $74.48K 10-Q · filed 2019-08-09 | $192.00K 10-Q · filed 2019-08-09 | $241.34K derived: sum of 3 quarters · filed 2020-03-17 | $367.26K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2019-03-31 | $117.53K 10-Q · filed 2019-05-10 | $166.87K derived: sum of 2 quarters · filed 2020-03-17 | $292.78K derived: sum of 3 quarters · filed 2020-03-17 | $480.99K derived: sum of 4 quarters · filed 2020-03-17 | |
| 2018-12-31 | $49.34K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $175.26K derived: sum of 2 quarters · filed 2020-03-17 | $363.46K derived: sum of 3 quarters · filed 2020-03-17 | $535.64K 10-K · filed 2020-03-17 | $535.33K 10-K · filed 2019-03-18 |
| 2018-09-30 | $125.92K 10-Q · filed 2019-11-12 | $314.12K derived: sum of 2 quarters · filed 2019-11-12 | $486.30K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $188.21K 10-Q · filed 2019-08-09 | $360.38K 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $175.31K 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $790.23K 10-K · filed 2019-03-18 | ||||
| 2014-12-31 | -$1.55M 10-K · filed 2016-02-29 | -$2.44M derived: sum of 2 quarters · filed 2016-02-29 | -$3.30M derived: sum of 3 quarters · filed 2016-02-29 | -$4.15M 10-K · filed 2017-03-15 | |
| 2014-09-30 | -$892.03K 10-K · filed 2016-02-29 | -$1.75M derived: sum of 2 quarters · filed 2016-02-29 | -$2.60M 10-Q · filed 2015-11-09 | -$3.48M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$858.00K 10-K · filed 2016-02-29 | -$1.71M 10-Q · filed 2015-08-04 | -$2.58M derived: sum of 3 quarters · filed 2016-02-29 | -$3.44M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$854.30K 10-K · filed 2016-02-29 | -$1.73M derived: sum of 2 quarters · filed 2016-02-29 | -$2.58M derived: sum of 3 quarters · filed 2016-02-29 | -$2.68M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$872.41K 10-K · filed 2015-03-03 | -$1.73M derived: sum of 2 quarters · filed 2015-03-03 | -$1.82M derived: sum of 3 quarters · filed 2015-03-03 | -$1.82M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$857.50K 10-K · filed 2015-03-03 | -$949.66K derived: sum of 2 quarters · filed 2015-03-03 | -$949.74K 10-Q · filed 2014-11-10 | -$949.84K derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-06-30 | -$92.16K 10-K · filed 2015-03-03 | -$92.23K 10-Q · filed 2014-07-31 | -$92.33K derived: sum of 3 quarters · filed 2015-03-03 | -$92.47K derived: sum of 4 quarters · filed 2015-03-03 | |
| 2013-03-31 | -$75.00 10-K · filed 2015-03-03 | -$180.00 derived: sum of 2 quarters · filed 2015-03-03 | -$317.00 derived: sum of 3 quarters · filed 2015-03-03 | -$773.00 derived: sum of 4 quarters · filed 2015-03-03 | |
| 2012-12-31 | -$105.00 10-K · filed 2014-03-07 | -$242.00 derived: sum of 2 quarters · filed 2014-03-07 | -$698.00 derived: sum of 3 quarters · filed 2014-03-07 | -$951.00 10-K · filed 2015-03-03 | |
| 2012-09-30 | -$137.00 10-K · filed 2014-03-07 | -$593.00 derived: sum of 2 quarters · filed 2014-03-07 | -$846.00 10-Q · filed 2013-11-05 | -$1.18K derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-06-30 | -$456.00 10-K · filed 2014-03-07 | -$709.00 10-Q · filed 2013-08-01 | -$1.04K derived: sum of 3 quarters · filed 2014-03-07 | -$1.45K derived: sum of 4 quarters · filed 2014-03-07 | |
| 2012-03-31 | -$253.00 10-K · filed 2014-03-07 | -$584.00 derived: sum of 2 quarters · filed 2014-03-07 | -$992.00 derived: sum of 3 quarters · filed 2014-03-07 | -$1.50K derived: sum of 4 quarters · filed 2014-03-07 | |
| 2011-12-31 | -$331.00 10-K · filed 2013-03-18 | -$739.00 derived: sum of 2 quarters · filed 2013-03-18 | -$1.24K derived: sum of 3 quarters · filed 2013-03-18 | -$1.84K 10-K · filed 2014-03-07 | |
| 2011-09-30 | -$408.00 10-K · filed 2013-03-18 | -$912.00 derived: sum of 2 quarters · filed 2013-03-18 | -$1.51K 10-Q · filed 2012-11-09 | -$2.34K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | -$504.00 10-K · filed 2013-03-18 | -$1.10K 10-Q · filed 2012-08-07 | -$1.93K derived: sum of 3 quarters · filed 2013-03-18 | -$3.39K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$601.00 10-K · filed 2013-03-18 | -$1.43K derived: sum of 2 quarters · filed 2013-03-18 | -$2.89K derived: sum of 3 quarters · filed 2013-03-18 | -$5.95K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2010-12-31 | -$825.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$2.29K derived: sum of 2 quarters · filed 2013-03-18 | -$5.35K derived: sum of 3 quarters · filed 2013-03-18 | -$9.70K 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$1.46K 10-Q · filed 2011-11-04 | -$4.53K derived: sum of 2 quarters · filed 2011-11-04 | -$8.88K 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | -$3.06K 10-Q · filed 2011-08-05 | -$7.41K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$25.18K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |